cytidine monophosphate has been researched along with etoposide in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (66.67) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cao, DC; Higashigawa, M; Ido, M; Inamochi, H; Kagawa, Y; Kakitou, H; Matsui, K; Sakurai, M; Yamada, S | 1 |
| Andoh, K; Fujimoto, H; Funasako, M; Hata, N; Itoh, K; Itoh, Y; Nakai, S; Nishi, T; Ohata, M; Ono, H; Sato, H; Sato, Y; Taniji, M; Ueda, A | 1 |
| Higa, T; Kasai, M; Kiyama, Y; Kobayashi, N; Masauzi, N; Naohara, T; Ogasawara, M; Ohizumi, H; Saito, M; Suzuki, G | 1 |
| Azuma, T; Hara, M; Kojima, K; Narumi, H; Shinagawa, K | 1 |
| Horikoshi, A; Hosokawa, Y; Sawada, S; Takei, K | 1 |
| Hatta, Y; Hirabayashi, Y; Horikoshi, A; Iriyama, N; Kobayashi, S; Kodaira, H; Matsukawa, Y; Miura, K; Takahashi, H; Takeuchi, J; Uchino, Y | 1 |
3 trial(s) available for cytidine monophosphate and etoposide
| Article | Year |
|---|---|
[Treatment of refractory hematologic malignancies by combination of cytarabine ocfosfate and etoposide].
Topics: Acute Disease; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Arabinonucleotides; Cytidine Monophosphate; Drug Administration Schedule; Etoposide; Female; Humans; Leukemia; Male; Middle Aged | 1996 |
[A combination chemotherapy with cytarabine ocfosfate, low dose etoposide, and G-CSF for the treatment of high risk MDS (RAEB, RAEBt)--a pilot study].
Topics: Aged; Anemia, Refractory, with Excess of Blasts; Antineoplastic Combined Chemotherapy Protocols; Arabinonucleotides; Bone Marrow; Cytidine Monophosphate; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Humans; Male; Middle Aged; Pilot Projects; Risk | 1998 |
The value of oral cytarabine ocfosfate and etoposide in the treatment of refractory and elderly AML patients.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Arabinonucleotides; Cytidine Monophosphate; Etoposide; Female; Humans; Kaplan-Meier Estimate; Leukemia, Myeloid, Acute; Male; Middle Aged; Neoplasm Recurrence, Local | 2008 |
3 other study(ies) available for cytidine monophosphate and etoposide
| Article | Year |
|---|---|
Combined oral administration of etoposide and arabinofuranosylcytosine-5'-stearylphosphate enhances the antitumor effect against P388 ascites tumors.
Topics: Administration, Oral; Animals; Antineoplastic Combined Chemotherapy Protocols; Arabinonucleotides; Cytidine Monophosphate; Etoposide; Leukemia P388; Male; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Time Factors; Treatment Outcome | 1994 |
[Five cases of myelodysplastic syndrome treated with cytarabine ocfosfate].
Topics: Administration, Oral; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Arabinonucleotides; Cytidine Monophosphate; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Humans; Male; Middle Aged; Myelodysplastic Syndromes; Remission Induction | 1996 |
Efficacy of oral cytarabine ocfosfate and etoposide in the treatment of elderly patients with higher-risk myelodysplastic syndromes compared to that in elderly acute myeloid leukemia patients.
Topics: Administration, Oral; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Arabinonucleotides; Cytidine Monophosphate; Disease-Free Survival; Etoposide; Female; Humans; Kaplan-Meier Estimate; Leukemia, Myeloid, Acute; Male; Myelodysplastic Syndromes; Treatment Outcome | 2013 |